ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0210

AKI!Now: Defining Excellence in the Prevention of and Care for Patients with AKI

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Cerda, Jorge, Albany Medical College, Albany, New York, United States
  • Parikh, Samir M., Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
  • Koyner, Jay L., University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States
  • Vijayan, Anitha, Washington University in St Louis, St Louis, Missouri, United States
  • Goldstein, Stuart, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
  • Liu, Kathleen D., University of California San Francisco, San Francisco, California, United States
  • Ostermann, Marlies, Guy's and St Thomas' NHS Foundation Trust, London, London, United Kingdom
  • Agarwal, Anupam, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Okusa, Mark D., University of Virginia Medical Center, Charlottesville, Virginia, United States

Group or Team Name

  • AKI!Now Initiative of the American Society of Nephrology
Background

ASN is committed to define excellence in AKI prevention and care to transform management, reduce morbidity, mortality and improve long-term outcomes. AKI!Now addresses a set of well-defined objectives to achieve those goals.

Methods

The AKI!Now initiative has developed a broad education program that bridges the continuum from basic investigation to clinical studies focused on early recognition, intervention, and effective therapies with a patient-centered focus

Results

Workgroups and tasks: Basic Science: AKI-Specific Early Interventions: Leverage basic science discoveries to innovate in AKI prevention, diagnosis, and treatment; develop a centralized research portal; promote AKI research and translational initiatives; create a roadmap to facilitate discovery and novel interventions; and enhance communication within the community. AKI Recognition and Clinical Interventions: Artificial Intelligence (AI): Design fair and equitable AI tools among physicians and researchers; and provide expert input on pathways to implement AI tools in all clinical contexts. Post-AKI Recovery: Identify mechanisms of repair to identify treatment strategies to accelerate recovery; prevent adverse outcomes and identify areas of priority research; promote comparative effectiveness research benchmarks; develop, test, and promote strategies to build capacity for post-AKI care. Public Awareness and Education: Leverage existing and develop novel education processes for health professionals and patients and multiple resources including the AKI!Now Compendium, focusing on AKI recognition, management, and recovery; collaboratively emphasize the role of continuous quality improvement in AKI recognition and care, and include patients and families in the healing process.

Conclusion

AKI is common, serious, under-recognized across the life span, and associated with severe risk of progressive adverse outcomes. Education at all levels; use of AI to improve pattern recognition, prevention, and management; development of novel specific therapies through better understanding of AKI mechanisms; and appropriate post-AKI recovery care will alleviate the severe short- and long-term individual and societal AKI impacts.